Clinical Trials Directory

Trials / Completed

CompletedNCT01573858

Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome

Effect of Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial (PCOSAct)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,000 (actual)
Sponsor
Heilongjiang University of Chinese Medicine · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The objectives of the present trial are to test the following three hypotheses in anovulatory women with PCOS: 1. Acupuncture protocol 1 plus CC (Arm A) is more likely to result in live birth than acupuncture protocol 2 combined with CC (Arm B), 2. Acupuncture protocol 2 plus CC (Arm B) is more likely to result in live birth than acupuncture protocol 1 plus placebo (Arm C), 3. Acupuncture protocol 1 plus placebo (Arm C) is more likely to result in live birth than acupuncture protocol 2 plus placebo (Arm D).

Detailed description

This is a multicenter, randomized, controlled, 2 by 2 factorial clinical trial for Chinese women with PCOS. Primary outcomes: \- Live birth rate Secondary outcomes: * Ovulation rate * Ongoing pregnancy rate * Multiple pregnancy rate * Miscarriage rate * Hormonal profile * Metabolic profile * Side effect profile

Conditions

Interventions

TypeNameDescription
OTHERAcupuncture treatment 1Two sets of acupuncture points will be alternated every second treatment. The first set consists of CV3, CV 6, and ST 29 bilaterally,SP 6 and SP 9 bilaterally. Needles will also be placed in LI bilaterally and GV 20. CV 3, CV 6, ST 29, SP 6, and SP 9 will be connected to and electrical stimulator and stimulated with low-frequency EA of 2Hz, 0.3 ms.
OTHERAcupuncture treatment 2Needles will be inserted to a depth of \<5 mm, one in each shoulder and on in each upper arm at non-acupuncture points. Electrodes will be attached to the needles and the stimulator will be turned on at an intensity of zero (no active current) in order to mimic EA in the acupuncture treatment 1. No manual stimulation of the needles will be performed.
OTHERCCCC 50 mg every day for 5 days (day 3-7 of cycle), for a total of 4 cycles. Non-response will be defined after 4 weeks of CC placebo administration with 3 consecutive weekly negative P4 and hCG levels. Then during the fifth week a higher dose consisting of one more tablet per day (up to 3 tablets per day at third or fourth cycles, if they remain non-responders) will be given 5 days.
OTHERCC placeboCC placebo 50 mg every day for 5 days (day 3-7 of cycle), for a total of 4 cycles. Non-response will be defined after 4 weeks of CC Placebo administration with 3 consecutive weekly negative P4 and hCG levels. Then during the fifth week a higher dose consisting of one more tablet per day (up to 3 tablets per day at third or fourth cycles, if they remain non-responders) will be given 5 days.

Timeline

Start date
2012-07-06
Primary completion
2014-11-08
Completion
2015-10-07
First posted
2012-04-10
Last updated
2021-08-25

Locations

25 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01573858. Inclusion in this directory is not an endorsement.